Preferential HDAC6 inhibitors derived from HPOB exhibit synergistic antileukemia activity in combination with decitabine by Tretbar, Maik, Schliehe-Diecks, Julian, von Bredow, Lukas, Tan, Kathrin, Roatsch, Martin, Tu, Jia-Wey, Kemkes, Marie, Sönnichsen, Melf, Schöler, Andrea, Borkhardt, Arndt, Bhatia, Sanil, Hansen, Finn K.

Get full text

Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia by Fischer, Fabian, Schliehe-Diecks, Julian, Tu, Jia-Wey, Gangnus, Tanja, Ho, Yu Lin, Hebeis, Mara, Alves Avelar, Leandro A., Scharov, Katerina, Watrin, Titus, Kemkes, Marie, Stachura, Pawel, Daugs, Katharina, Biermann, Lukas, Kremeyer, Josefa, Horstick, Nadine, Span, Ingrid, Pandyra, Aleksandra A., Borkhardt, Arndt, Gohlke, Holger, Kassack, Matthias U., Burckhardt, Bjoern B., Bhatia, Sanil, Kurz, Thomas

Get full text